{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:13:58Z","timestamp":1762506838534,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","meddos.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.meddos.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T01:46:45Z","timestamp":1468115205000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Ruijie","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2016.06.002_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","article-title":"Radical prostatectomy, external beam radiotherapy < 72Gy, external beam radiotherapy > or = 72Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"58","author":"Kupelian","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high dose conformal radiation therapy in early stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2010.02.022","article-title":"Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial","volume":"96","author":"Al-Mamgani","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","article-title":"Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer","volume":"84","author":"Zelefsky","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2016.06.002_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prro.2014.03.003","article-title":"A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer","volume":"5","author":"Mellon","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2012.01.016","article-title":"Comparison between external beam radiotherapy (70Gy\/74Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients","volume":"103","author":"Goldner","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"suppl. 1","key":"10.1016\/j.meddos.2016.06.002_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.meddos.2016.06.002_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1200\/JCO.2010.31.7305","article-title":"Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial","volume":"29","author":"Crook","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2007.12.024","article-title":"Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer","volume":"72","author":"Ferrer","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I-125 prostate brachytherapy in clinically localized prostate cancer: seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0090-4295(98)00153-8","article-title":"Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis","volume":"51","author":"Polascik","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.meddos.2016.06.002_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(02)02733-5","article-title":"Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer","volume":"53","author":"Martinez","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy\u05f3s 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib14","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2010.10.015","article-title":"High-Dose-Rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer","volume":"81","author":"Demanes","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e3181b9cd2f","article-title":"High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer","volume":"33","author":"Martinez","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"issue":"suppl. 1","key":"10.1016\/j.meddos.2016.06.002_bib16","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.brachy.2010.02.080","article-title":"Extended follow up of high-dose-rate brachytherapy as monotherapy for intermediate- risk prostate cancer","volume":"9","author":"Rogers","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.meddos.2016.06.002_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2010.02.013","article-title":"Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54Gy in nine fractions","volume":"80","author":"Yoshioka","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ijrobp.2011.04.031","article-title":"High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence","volume":"82","author":"Hoskin","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate after loading brachytherapy for localized prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib21","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ijrobp.2011.01.039","article-title":"Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis","volume":"82","author":"Coen","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","article-title":"Urinary obstruction in prostate cancer patients from the Dutch trial (68Gy vs.78Gy): Relationships with local dose, acute effects, and baseline characteristics","volume":"78","author":"Heemsbergen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib23","doi-asserted-by":"crossref","first-page":"853487","DOI":"10.1155\/2012\/853487","article-title":"Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer","volume":"2012","author":"Hunter","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.meddos.2016.06.002_bib24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1464-410X.2012.11385.x","article-title":"Secondary cancers after intensity modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention","volume":"110","author":"Zelefsky","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.meddos.2016.06.002_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2012.03.004","article-title":"Meta analysis of alpha\/beta ratio for prostate cancer in the presence of an overall time factor. Bad news, good news or no news?","volume":"85","author":"Vogelius","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"year":"2006","series-title":"Klinische Strahlenbiologie: Kurz und B\u00fcndig","author":"Herrmann","key":"10.1016\/j.meddos.2016.06.002_bib28"},{"key":"10.1016\/j.meddos.2016.06.002_bib29","series-title":"The role of dose rate in brachytherapy","first-page":"69","author":"Dutreix","year":"1997"},{"key":"10.1016\/j.meddos.2016.06.002_bib30","doi-asserted-by":"crossref","unstructured":"ICRU Report 83: Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). J. ICRU, 2010, 10(1). Oxford University Press. http:\/\/dx.doi.org\/10.1093\/jicru\/ndq002.","DOI":"10.1093\/jicru\/ndq002"},{"issue":"1","key":"10.1016\/j.meddos.2016.06.002_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prro.2014.03.003","article-title":"A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer","volume":"5","author":"Mellon EA1","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.meddos.2016.06.002_bib32","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2011.09.015","article-title":"A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment","volume":"83","author":"Quan","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2016.06.002_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/0973-1482.138200","article-title":"Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: a dosimetric comparison","volume":"10","author":"Kinhikar","year":"2014","journal-title":"J. Cancer. Res. Ther."},{"key":"10.1016\/j.meddos.2016.06.002_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature","volume":"61","author":"Buda\u00a8us","year":"2012","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.meddos.2016.06.002_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2012.07.004","article-title":"High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results","volume":"85","author":"Zamboglou","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2016.06.002_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2009.07.1723","article-title":"Biochemical disease free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D(90) \u2265 180Gy","volume":"78","author":"Go\u00b4mez-Iturriaga","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2016.06.002_bib38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1088\/0031-9155\/60\/3\/1237","article-title":"Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy","volume":"60","author":"Murray","year":"2015","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2016.06.002_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.meddos.2016.06.002_bib40","doi-asserted-by":"crossref","first-page":"i851","DOI":"10.1136\/bmj.i851","article-title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"Br. Med. J."}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394716300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394716300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:09:05Z","timestamp":1718687345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394716300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["S0958394716300231"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2016.06.002","relation":{},"ISSN":["0958-3947"],"issn-type":[{"type":"print","value":"0958-3947"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Association of Medical Dosimetrists. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}